Lung Cancer
Volume 72, Issue 1 , Pages 39-44 , April 2011

Inoperable early stage non-small cell lung cancer: Comorbidity, patterns of care and survival

  • S.L. Smith

      Affiliations

    • Radiation Therapy Program, British Columbia Cancer Agency, Vancouver Island Centre, 410 Lee Avenue, Victoria, British Columbia V8R 6V5, Canada
    • Corresponding Author InformationCorresponding author at: Vancouver Island Cancer Centre, 2410 Lee Avenue, Victoria, BC V8R 6V5, Canada. Tel.: +(250) 519 5500; fax: +(250) 519 2018.
    • ,
  • D. Palma

      Affiliations

    • Radiation Therapy Program, British Columbia Cancer Agency, Vancouver Cancer Centre, Vancouver, 600 West 10th Ave, V5Z 4E5 British Columbia, Canada
    • VU University Medical Centre, De Boelelaan 1117, Amsterdam 1007 MB, Netherlands
    • ,
  • T. Parhar

      Affiliations

    • Radiation Therapy Program, British Columbia Cancer Agency, Vancouver Island Centre, 410 Lee Avenue, Victoria, British Columbia V8R 6V5, Canada
    • ,
  • C.S. Alexander

      Affiliations

    • Radiation Therapy Program, British Columbia Cancer Agency, Vancouver Island Centre, 410 Lee Avenue, Victoria, British Columbia V8R 6V5, Canada
    • ,
  • E.S. Wai

      Affiliations

    • Radiation Therapy Program, British Columbia Cancer Agency, Vancouver Island Centre, 410 Lee Avenue, Victoria, British Columbia V8R 6V5, Canada

Received 19 April 2010 ,Revised 10 July 2010 ,Accepted 29 July 2010.

References 

  1. Wisnivesky JP, Bonomi M, Henschke C, Iannuzzi M, McGinn T. Radiation therapy for the treatment of unresected stage I–II non-small cell lung cancer. Chest. 2005;128:1461–1467
  2. Qiao X, Tullgren O, Lax I, Sirzon F, Lewensohn R. The role of radiotherapy in treatment of stage I non-small cell lung cancer. Lung Cancer. 2003;41:1–11
  3. Zimmermann FB, Bamberg M, Molls M, Jeremic B. Radiation therapy alone in early stage non-small cell lung cancer. Semin Surg Oncol. 2003;21:91–97
  4. Slotman BJ, Hian Njo K, Karim ABMF. Curative radiotherapy for technically operable stage I nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys. 1994;29:33–37
  5. Sibley MD, Jamieson MD, Marks MD, Anscher MD, Prosnitz MD. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience. Int J Radiat Oncol Biol Phys. 1998;40:149–154
  6. Rowell NP, Williams CJ. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review. Thorax. 2001;56:628–638
  7. Gauden SJ, Tripcony L. The curative treatment by radiation therapy alone of stage I non-small cell lung cancer in a geriatric population. Lung Cancer. 2001;32:71–79
  8. National Comprehensive Cancer Network Clinical Practice Guideline: Non-Small Cell Lung Cancer. http://www.nccn.org/professionals/physician_gls/PDF/nscl.pdf. 10-3-2010. Ref Type: Electronic Citation.
  9. BC Cancer Agency Cancer Management Guidelines. http://www.bccancer.bc.ca/HPI/CancerManagementGuidelines/default.htm. 10-3-2010. Ref Type: Electronic Citation.
  10. Vrdoljak E, Mise K, Sapunar D, Rozga A, Marusic M. Survival analysis of untreated patients with non-small-cell lung cancer. Chest. 1994;106:1797–1800
  11. Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol. 1989;62:679–694
  12. Cheung PC, Mackillop WJ, Dixon P, Brundage MD, Youssef YM, Zhou S. Involved-field radiotherapy alone for early-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2000;48:703–710
  13. Charlson ME, Pompei P, Ales KL, Mackenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383
  14. Koppie TM, Serio AM, Vickers AJ, Vora K, Dalbagni G, Donat SM, et al. Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer. Cancer. 2008;112:2384–2392
  15. Fairchild A, Harris K, Barnes E, Wong R, Lutz S, Bezjak A, et al. Palliative thoracic radiotherapy for lung cancer: a systematic review. J Clin Oncol. 2008;26:4001–4011
  16. McGarry RC, Song G, des Rosiers P, Timmerman R. Observation-only management of early stage, medically inoperable lung cancer. Chest. 2002;121:1155–1158
  17. Palma D, Tyldesley S, Sheehan F, Mohamed I, Smith S, Wai E, et al. Stage I non-small cell lung cancer (NSCLC) in patients aged 75 years and above: does age determine survival after radical treatment?. J Thorac Oncol. 2010;5:818–824
  18. Kyasa MJ, Jazieh AR. Characteristics and outcomes of patients with unresected early-stage non-small cell lung cancer. South Med J. 2002;95:1149–1152
  19. Wisnivesky JP, Halm E, Bonomi M, Powell C, Bagiella E. Effectiveness of radiation therapy for elderly patients with unresected stage I and II non-small cell lung cancer. Am J Respir Crit Care Med. 2010;181:264–269
  20. Powell JW, Dexter E, Scalzetti EM, Bogart JA. Treatment advances for medically inoperable non-small-cell lung cancer: emphasis on prospective trials. Lancet Oncol. 2009;10:885–894
  21. Dahele M, Brade A, Pearson S, Bezjak A. Stereotactic radiation therapy for inoperable, early-stage non-small-cell lung cancer. CMAJ. 2009;180:1326–1328
  22. Haasbeek CJA, Senan S, Smit EF, Paul MA, Slotman BJ, Lagerwaard FJ. Critical review of nonsurgical treatment options for stage I non-small cell lung cancer. Oncologist. 2008;13:309–319
  23. Lagerwaard FJ, Haasbeek CJA, Smit EF, Slotman BJ, Senan S. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2008;70:685–692
  24. Nguyen NP, Garland L, Welsh J, Hamilton R, Cohen D, Vinh-Hung V. Can stereotactic fractionated radiation therapy become the standard of care for early stage non-small cell lung carcinoma. Cancer Treat Rev. 2008;34:719–727
  25. Grills IS, Mangona VS, Welsh R, Chmielewski G, McInerney E, Martin S, et al. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. J Clin Oncol. 2010;28:928–935
  26. Palma DA, Visser O, Lagerwaard FJ, Senan S. Treatment utilization and survival for elderly patients with stage I NSCLC: a population-based time-trend analysis. In: ESMO IASLC Conf 2010 Abstract 172. 2010;Ref Type: Abstract
  27. Bentzen SM, Saunders MI, Dische S, Parmar MK. Updated data for CHART in NSCLC: further analysis. Radiother Oncol. 2000;55:86–87
  28. Audisio RA, Zbar AP, Jaklitsch MT. Surgical management of oncogeriatric patients. J Clin Oncol. 2007;25:1924–1929
  29. Yan TD, Black D, Bannon PG, McCaughan BC. Systematic review and meta-analysis of randomized and nonrandomized trials on safety and efficacy of video-assisted thoracic surgery lobectomy for early-stage non-small-cell lung cancer. J Clin Oncol. 2009;27:2553–2562
  30. Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help: a SIOG surgical task force prospective study. Crit Rev Oncol Hematol. 2008;65:156–163
  31. Kates M, Perez X, Gribetz J, Swanson SJ, McGinn T, Wisnivesky JP. Validation of a model to predict perioperative mortality from lung cancer resection in the elderly. Am J Respir Crit Care Med. 2009;179:390–395
  32. Sterling TD, Rosenbaum WL, Weinkam JJ. Bias in the attribution of lung cancer as cause of death and its possible consequences for calculating smoking-related risks. Epidemiology. 1992;3:11–16

PII: S0169-5002(10)00378-8

doi: 10.1016/j.lungcan.2010.07.015

Lung Cancer
Volume 72, Issue 1 , Pages 39-44 , April 2011

Article Tools

* Image Usage & Resolution